Peer Review reports
From: The prognostic value of neuromedin U in patients with hepatocellular carcinoma
| Original Submission | ||
|---|---|---|
| 17 Mar 2019 | Submitted | Original manuscript |
| 23 May 2019 | Reviewed | Reviewer Report - Tatsuya Yamashita |
| 22 Oct 2019 | Reviewed | Reviewer Report - Reviewer 2 |
| 25 Nov 2019 | Author responded | Author comments - Qiao Li |
| Resubmission - Version 2 | ||
| 25 Nov 2019 | Submitted | Manuscript version 2 |
| 16 Dec 2019 | Reviewed | Reviewer Report - Tatsuya Yamashita |
| 18 Dec 2019 | Reviewed | Reviewer Report - Reviewer 2 |
| 24 Dec 2019 | Author responded | Author comments - Qiao Li |
| Resubmission - Version 3 | ||
| 24 Dec 2019 | Submitted | Manuscript version 3 |
| 9 Jan 2020 | Author responded | Author comments - Qiao Li |
| Resubmission - Version 4 | ||
| 9 Jan 2020 | Submitted | Manuscript version 4 |
| Publishing | ||
| 13 Jan 2020 | Editorially accepted | |
| 3 Feb 2020 | Article published | 10.1186/s12885-020-6532-1 |
You can find further information about peer review here.